« Return to News | CROs/Service Providers

Aptiv Solutions opens new office

Thursday, November 29, 2012 01:52 PM

Reston, Va.-based Aptiv Solutions, a biopharmaceutical and medical device development services company with a focus on adaptive clinical trial design, simulation and execution, opened a new office in Durham, N.C., combining offices with its subsidiary Trio Clinical Resourcing.

The decision to combine the offices arose from staff growth and the desire to co-locate the North Carolina-based teams. The new location includes team members from the clinical, data management, regulatory, translational sciences, information technology, finance and human resources teams for Aptiv Solutions and the Trio Clinical Resourcing team.

“We continue to experience rapid growth as we expand to meet the expansion in our client base,” said Pat Donnelly, chairman and CEO of Aptiv Solutions. “Our new office not only accommodates our current staff levels, but allows for the anticipated future growth of our North Carolina operations.”

Aptiv Solutions’ services including adaptive clinical trials, translational research services, regulatory services, pharmacovigilance, clinical staffing and operational support from a global CRO. It employs over 850 in North America, Eastern and Western Europe, Israel, and Japan.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.